Holen Sie sich die Stockscreener-App
3.625
1.39%
0.035
Scpharmaceuticals Inc Aktie (SCPH) Neueste Nachrichten
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by State Street Corp - Defense World
scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit - Yahoo Finance
Sanctuary Advisors LLC Takes $75,000 Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
27,169 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by XTX Topco Ltd - Defense World
BNP Paribas Financial Markets Has $26,000 Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Charles Schwab Investment Management Inc. Sells 3,312 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
SC Pharmaceuticals Inc (SCPH-Q) QuotePress Release - The Globe and Mail
The Manufacturers Life Insurance Company Invests $57,000 in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
2 "Strong Buy"-Rated Biotech Stocks With 303% To 446% Upside Potential - Barchart
Tscan Therapeutics Inc (TCRX-Q) QuotePress Release - The Globe and Mail
Head to Head Survey: Cyclerion Therapeutics (NASDAQ:CYCN) vs. scPharmaceuticals (NASDAQ:SCPH) - Defense World
Wearable Injector Market Growth in Future Scope 2024-2031 | - openPR
ScPharmaceuticals Stock Falls After Noting Possible FDA Submission Delay - MarketWatch
MetLife Investment Management LLC Grows Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
SCPH (scPharmaceuticals) 9-Day RSI : 45.28 (As of Dec. 04, 2024) - GuruFocus.com
Jefferies cuts scPharmaceuticals stock target, keeps buy rating on Q3 results - Investing.com UK
Suvretta Capital Management LLC Makes New $9.34 Million Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
Rubric Capital Management LP Boosts Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
scPharmaceuticals (STU:2SX) Cash Flow from Operations : €-64.68 Mil (TTM As of Sep. 2024) - GuruFocus.com
scPharmaceuticals (STU:2SX) Float Percentage Of Total Shares Outstanding : 88.47% (As of Nov. 21, 2024) - GuruFocus.com
scPharmaceuticals (STU:2SX) Intrinsic Value: Projected FCF : €-6.70 (As of Nov. 21, 2024) - GuruFocus.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term - Simply Wall St
HC Wainwright Expects Reduced Earnings for scPharmaceuticals - MarketBeat
King Luther Capital Management Corp's Strategic Acquisition in s - GuruFocus.com
Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
500: Something went wrong - Investing.com India
SCPH stock touches 52-week low at $3.24 amid market challenges - Investing.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript - Insider Monkey
scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
The one-year earnings decline has likely contributed toscPharmaceuticals' (NASDAQ:SCPH) shareholders losses of 33% over that period - Simply Wall St
Earnings call: scPharmaceuticals reports robust Q3 growth, eyes FDA nod By Investing.com - Investing.com UK
ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates - MSN
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
scPharmaceuticals Reports Strong Growth in Q3 2024 - TipRanks
ScPharmaceuticals Q3 Loss Widens, Revenue Rises - Marketscreener.com
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
scPharmaceuticals' FUROSCIX Revenue Surges 164% YoY to $10M in Q3, Expands FDA Approval | SCPH Stock News - StockTitan
Certain Common Stock of scPharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2024. - Marketscreener.com
scPharmaceuticals (SCPH) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - The Manila Times
scPharmaceuticals Sets Q3 2024 Earnings Call for November 13 | SCPH Stock News - StockTitan
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
Scpharmaceuticals announces FDA acceptance of NDA for Furoscix - Reuters
KING LUTHER CAPITAL MANAGEMENT CORP Expands Stake in scPharmaceu - GuruFocus.com
TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval - Investing.com India
TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval By Investing.com - Investing.com South Africa
Third Time's The Charm For ScPharma? - RTTNews
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 - GlobeNewswire
Congestive Heart Failure Treatment Market 2034: Clinical - openPR
The Attractiveness of Investing In scPharmaceuticals Inc (SCPH) is Growing - Knox Daily
Daily Progress: scPharmaceuticals Inc (SCPH) Drop -2.33, Closing at 3.97 - The Dwinnex
scPharmaceuticals GAAP EPS of -$0.41 misses by $0.05, revenue of $3.8M beats by $0.38M - MSN
Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? - MSN
351,806 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Acquired by Bank of Montreal Can - MarketBeat
3.26%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):